External Affairs

Chair: Ray Harris

External Affairs is PSI’s newest committee. Our remit is to promote, amongst members of the pharmaceutical industry and the general public, a proper understanding of risks, benefits and associated statistical issues as they relate to pharmaceutical research, development, manufacturing and marketing.

This will be achieved by:

  • A programme of interactions with the media, including the submission of letters and articles to learned and lay press and other media outlets.
  • A programme of activities designed to highlight to the pharmaceutical industry (e.g., companies and professional bodies) the importance of statistics and appropriate statistical methods.
  • A programme of activities designed to highlight to people and bodies of influence (e.g., political organisations and politicians, regulatory bodies) the importance of statistics and appropriate statistical methods.
  • Responding to requests for a PSI perspective on relevant statistical matters.
  • Responding to emerging statistical issues of public and/or industry significance with written or oral submissions.
  • Promoting interaction between PSI and its members and the media for example, by encouraging journalists to attend and participate in PSI events; by encouraging PSI committees to hold events that will attract journalists and interest the audiences they serve.

Latest News


Show all news

EventsFuture Events


  • Network Meta Analysis (NMA) for Statisticians - Dates: 07 – 08 Mar, 2019

    This intensive course will cover all basic and advanced aspects of synthesis of evidence from studies comparing competing treatments for the same health condition. By the end of this course participants will have an understanding of the role and potential of network meta-analysis, the principles, steps and statistical methods involved; the biases that can distort indirect comparisons and network meta-analysis.
  • PSI Webinar: HTA Submissions in the UK - Dates: 21 – 21 Jan, 2019

    There is a simple equation for access in the UK: Access = Reimbursement + Uptake. Yet, whilst a simple and logical approach, each component is challenging to achieve. This webinar focuses on the National Reimbursement side: the National Institute for Health and Care Excellence (NICE) - who they are, what is involved in the Health Technology Appraisal (HTA) assessment, how they make decisions.
UNI of Southampton

Senior Medical Statistician (Scientific Lead)

read more...

AstraZeneca Logo

Senior Statistician, Quantitative Biology

read more...

BI_Logo_Blue

Principal Statistician

read more...

~WRD000

Senior Biostatistician

read more...

Resized PAREXEL Logo with Tagline_Small_Full Color

Senior/Principal Biostatistician

read more...

LillyLogo_RGB_Red

Statistician for HTA/Medical Affairs (contractor and permanent)

read more...

B899990 - EXECUTIVE DIRECTOR, HEALTH TECHNOLOGY ASSESSMENT (HTA) STATISTICS

Executive Director, Health Technology Assessment (HTA) Statistics

read more...

B900000 - EXECUTIVE DIRECTOR, HEALTH TECHNOLOGY ASSESSMENT (HTA) STATISTICS

Executive Director, Health Technology Assessment (HTA) Statistics

read more...

rochelogo_10p_2

Associate / Senior / Principal Statistical Scientist positions

read more...